Fusion of the tetanus toxin C fragment binding domain and Bcl-xL for protection of peripheral nerve neurons

Neurosurgery

Volumn 63, Issue 6, 2008, Pages 1175-1182

  Carlton, Erin ^a   Teng, Qingshan ^b   Federici, Thais ^b   Yang, Jun ^a   Riley, Jonathan ^a   Boulis, Nicholas M ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amyotrophic lateral sclerosis; Apoptosis; Clostridium toxin; Dorsal root ganglia; Motor neuron; Motor neuron disease; Peripheral neuropathy

Indexed keywords

GLUTAMIC ACID; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; PROTEIN BCL XL; TETANUS TOXIN; TETANUS TOXIN PROTEIN BCL XL FUSION PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL SURVIVAL; CHROMATOGRAPHY; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; EMBRYO; ESCHERICHIA COLI; EXCITOTOXICITY; EXPRESSION VECTOR; HEAVY CHAIN; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR CLONING; MOTONEURON; NERVE CELL; NERVE ENDING; NEUROPROTECTION; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PURIFICATION; PROTEIN TRANSPORT; RAT; SPINAL CORD NERVE CELL; SPINAL GANGLION;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; CELL SURVIVAL; CELLS, CULTURED; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; POSTERIOR HORN CELLS; RATS; RECOMBINANT FUSION PROTEINS; TETANUS TOXIN;

EID: 58149461546     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000334415.45003.EA     Document Type: Article

References (32)

1. Albarran B, To R, Stayton PS: A TAT-streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells. Protein Eng Des Sel 18:147-152, 2005.
2. Benn SC, Ay I, Bastia E, Chian RJ, Celia SA, Pepinsky RB, Fishman PS, Brown RH Jr, Francis JW: Tetanus toxin fragment C fusion facilitates protein delivery to CNS neurons from cerebrospinal fluid in mice. J Neurochem 95:1118-1131, 2005.
3. Bordet T, Castelnau-Ptakhine L, Fauchereau F, Friocourt G, Kahn A, Haase G: Neuronal targeting of cardiotrophin-1 by coupling with tetanus toxin C fragment. Mol Cell Neurosci 17:842-854, 2001.
4. Boulis NM, Noordmans AJ, Song DK, Imperiale MJ, Rubin A, Leone P, During M, Feldman EL: Adeno-associated viral vector gene expression in the adult rat spinal cord following remote vector delivery. Neurobiol Dis 14:535-541, 2003.
5. Campenot RB: Development of sympathetic neurons in compartmentalized cultures. II. Local control of neurite survival by nerve growth factor. Dev Biol 93:13-21, 1982.
6. Capowski EE, Schneider BL, Ebert AD, Seehus CR, Szulc J, Zufferey R, Aebischer P, Svendsen CN: Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy. J Neurosci Methods 163:338-349, 2007.
7. Evan GI, Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature 411:342-348, 2001.
8. Federici T, Liu JK, Teng Q, Vang J, Boulis NM: A means for targeting therapeutics to peripheral nervous system neurons with axonal damage. Neurosurgery 60:911-918, 2007.
9. Figueiredo DM, Hallewell RA, Chen LL, Fairweather NF, Dougan G, Savitt JM, Parks DA, Fishman PS: Delivery of recombinant tetanus-superoxide dismutase proteins to central nervous system neurons by retrograde axonal transport. Exp Neurol 145:546-554, 1997.
10. Fischer LR, Glass JD. Axonal degeneration in motor neuron disease. Neurodegener Dis 4:431-442, 2007.
11. Garrity-Moses ME, Teng Q, Krudy C, Yang J, Federici T, Boulis NM: X-linked inhibitor of apoptosis protein gene-based neuroprotection for the peripheral nervous system. Neurosurgery 59:172-182, 2006.
12. Garrity-Moses ME, Teng Q, Liu J, Tanase D, Boulis NM: Neuroprotective adeno-associated virus Bcl-xL gene transfer in models of motor neuron disease. Muscle Nerve 32:734-744, 2005.
13. Glass JD, Culver DG, Levey AI, Nash NR: Very early activation of m-calpain in peripheral nerve during Wallerian degeneration. J Neurol Sci 196:9-20, 2002.
14. Grumelli C, Verderio C, Pozzi D, Rossetto O, Montecucco C, Matteoli M: Internalization and mechanism of action of clostridial toxins in neurons. Neurotoxicology 26:761-767, 2005.
15. Kissa K, Mordelet E, Soudais C, Kremer EJ, Demeneix BA, BrûTet P, Coen L: In vivo neuronal tracing with GFP-TTC gene delivery. Mol Cell Neurosci 20:627-637, 2002.
16. Matsuoka N, Yukawa H, Ishii K, Hamada H, Akimoto M, Hashimoto N, Miyatake S: Adenovirus-mediated gene transfer of Bcl-xL prevents cell death in primary neuronal culture of the rat. Neurosci Lett 270:177-180, 1999.
17. Miana-Mena FJ, Roux S, Benichou JC, Osta R, Brûlet P: Neuronal activity-dependent membrane traffic at the neuromuscular junction. Proc Natl Acad Sci U S A 99:3234-3239, 2002.
18. Montecucco C, Schiavo G: Structure and function of tetanus and botulinum neurotoxins. Q Rev Biophys 28:423-472, 1995.
19. Montecucco C, Rossetto O, Schiavo G: Presynaptic receptor arrays for clostridial neurotoxins. Trends Microbiol 12:442-446, 2004.
20. Perreault MC, Bernier AP, Renaud JS, Roux S, Glover JC: C fragment of tetanus toxin hybrid proteins evaluated for muscle-specific transsynaptic mapping of spinal motor circuitry in the newborn mouse. Neuroscience 141:803-816, 2006.
21. Tanase K, Teng Q, Krishnaney AA, Liu JK, Garrity-Moses ME, Boulis NM: Cervical spinal cord delivery of a rabies G protein pseudotypcd lentiviral vector in the SOD-1 transgenic mouse. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. J Neurosurg Spine 1:128-136, 2004.
22. Teng Q, Garrity-Moses M, Federici T, Tanase D, Liu JK, Mazarakis ND, Azzouz M, Walmsley LE, Carlton E, Boulis NM: Trophic activity of Rabies G protein-pseudotyped equine infectious anemia viral vector mediated 1GF-1 motor neuron gene transfer in vitro. Neurobiol Dis 20:694-700, 2005.
23. Teng Q, Tanase D, Liu JK, Garrity-Moses ME, Baker KB, Boulis NM: Adenoviral clostridial light chain gene-based synaptic inhibition through neuronal synaptobrevin elimination. Gene Ther 12:108-119, 2005.
24. Tonello F, Pellizzari R, Pasqualato S, Grandi G, Peggion E, Montecucco C: Recombinant and truncated tetanus neurotoxin light chain: Cloning, expression, purification, and proteolytic activity. Protein Expr Purif 15:221-227, 1999.
25. Tsuchidd T, Ensini M, Morton SB, Baldassare M, Edlund T, Jessell TM, Pfaff SL: Topographic organization of embryonic motor neurons defined by expression of LIM homeobox genes. Cell 79:957-970, 1994.
26. Vincent AM, Feldman EL: Can drug screening lead to candidate therapies for testing in diabetic neuropathy? Antioxid Redox Signal 10:387-393, 2008.
27. Vincent AM, Mobley BC, Hiller A, Feldman EL: IGF-I prevents glutamate-induced motor neuron programmed cell death. Neurobiol Dis 16:407-116, 2004.
28. Vincent AM, Stevens MJ, Backus C, McLean LL, Feldman EL: Cell culture modeling to test therapies against hyperglycemia-mediated oxidative stress and injury. Antioxid Redox Signal 7:1494-1506, 2005.
29. Vukosavic S, Dubois-Dauphin M, Romero N, Przedborski S: Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 73:2460-2468, 1999.
30. Wang MS, Davis AA, Culver DG, Wang Q, Powers JC, Glass JD: Calpain inhibition protects against Taxol-induced sensorv neuropathy. Brain 127: 671-679, 2004.
31. Wang MS, Wu Y, Culver DG, Glass JD: Pathogenesis of axonal degeneration: Parallels between Wallerian degeneration and vincristine neuropathy. J Neuropathol Exp Neurol 59:599-606, 2000.
32. Yamamoto M, Wada N, Kitabatake Y, Watanabe D, Anzai M, Yokoyama M, Teranishi Y, Nakanishi S: Reversible suppression of glutamatergic neurotransmission of cerebellar granule cells in vivo by genetically manipulated expression of tetanus neurotoxin light chain. J Neurosci 23:6759-6767, 2003.